Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Net Income towards Common Stockholders: 2012-2025

Historic Net Income towards Common Stockholders for Phibro Animal Health (PAHC) over the last 14 years, with Jun 2025 value amounting to $43.5 million.

  • Phibro Animal Health's Net Income towards Common Stockholders rose 280.32% to $26.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.1 million, marking a year-over-year increase of 123.38%. This contributed to the annual value of $43.5 million for FY2025, which is 228.61% up from last year.
  • Per Phibro Animal Health's latest filing, its Net Income towards Common Stockholders stood at $43.5 million for FY2025, which was up 228.61% from $13.2 million recorded in FY2024.
  • Over the past 5 years, Phibro Animal Health's Net Income towards Common Stockholders peaked at $52.2 million during FY2021, and registered a low of $13.2 million during FY2024.
  • Moreover, its 3-year median value for Net Income towards Common Stockholders was $29.7 million (2023), whereas its average is $28.8 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first crashed by 55.43% in 2024, then skyrocketed by 228.61% in 2025.
  • MRY analysis of 5 years shows Phibro Animal Health's Net Income towards Common Stockholders stood at $52.2 million in 2021, then dropped by 7.34% to $48.4 million in 2022, then crashed by 38.58% to $29.7 million in 2023, then crashed by 55.43% to $13.2 million in 2024, then soared by 228.61% to $43.5 million in 2025.
  • Its Net Income towards Common Stockholders stands at $43.5 million for FY2025, versus $13.2 million for FY2024 and $29.7 million for FY2023.